SUNPHARMA's weekly performance was disappointing, with a return of -1.12%, indicating a decline in stock value. The stock's volatility was moderate at 14.56%, which is relatively lower compared to its peers. Despite this, SUNPHARMA underperformed its peers DRREDDY and DIVISLAB, but outperformed them in terms of volatility. However, it significantly underperformed HINDUNILVR, which posted a positive return.

[Volatility: 14.56%]